Investor Relations

Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).

Share price

Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD

Latest CEO Comments

APRIL 28, 2022

"Promising start to 2022"

Read the latest CEO comments from Nikolaj Sørensen

News flow

Regulatory Press Releases

Key financial figures

Group net revenue

592 MSEK
Last Twelve Months, Q221-Q122

Group EBITDA

-134 MSEK
Last Twelve Months, Q221-Q122

US Pharma segment EBIT

296 MSEK
Last Twelve Months, Q221-Q122

Cash position

434 MSEK
Q122
IR-Contact